Data analytics looms large as PharmStars digital health accelerator wraps first 'PharmU' startup class
Class is dismissed for PharmStars’ first cohort of digital health startup companies. The pharma-focused accelerator recently graduated 12 companies after a 10-week educational program and a final showcase meet-up with six pharma members – Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Sumitovant Biopharma, Takeda and Alexion (now part of AstraZeneca).
The final 12 – bumped up from an initial expected class size of 10 after 73 applications poured in – are now in various stages of talks with the pharma companies about next steps. While it’s too early to report any final deals or partnerships, PharmStars’ founder and CEO Naomi Fried applauded first-round efforts and expects there will be news in the upcoming weeks.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,300+ biopharma pros reading Endpoints daily — and it's free.